{"id":7315,"date":"2019-05-16T09:01:38","date_gmt":"2019-05-16T13:01:38","guid":{"rendered":"https:\/\/www.stockcalc.com\/blog\/BrianD\/?p=7315"},"modified":"2019-05-16T09:01:38","modified_gmt":"2019-05-16T13:01:38","slug":"booking-holdings-bkngnas-and-vertex-pharmaceuticals-vrtxnas-are-undervalued","status":"publish","type":"post","link":"https:\/\/www.stockcalc.com\/blog\/BrianD\/2019\/05\/16\/booking-holdings-bkngnas-and-vertex-pharmaceuticals-vrtxnas-are-undervalued\/","title":{"rendered":"Booking Holdings (BKNG:NAS) and Vertex Pharmaceuticals (VRTX:NAS) Are Undervalued"},"content":{"rendered":"

Stockcalc – Free Trial<\/h4>\n

Have a free look inside the StockCalc website at www.stockcalc.com<\/a><\/p>\n

\n
\n<\/hr>\n

I have used the analysis tools on the website stockcalc.com<\/a> to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com\/TopPicks.aspx<\/a>.<\/p>\n

Undervalued Stocks on NASDAQ<\/h4>\n

Today we are looking at companies that are considered undervalued based on the Analyst data in the StockCalc database.<\/p>\n

In the table below we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.<\/p>\n

There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.<\/p>\n

Today’s Data on NASDAQ<\/h4>\n

Today’s data is for companies listed on the NASDAQ<\/strong>.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Symbol<\/th>\nName<\/th>\nTarget Year<\/th>\nClose Price<\/th>\nTarget Price Mean<\/th>\nCurrency<\/th>\nTarget Price # of Estimates<\/th>\n<\/tr>\n
AMZN<\/td>\nAmazon.com Inc<\/td>\n2019<\/td>\n1889.980000<\/td>\n2252.0000<\/td>\nUSD<\/td>\n10<\/td>\n<\/tr>\n
GOOG<\/td>\nAlphabet Inc<\/td>\n2019<\/td>\n1164.270000<\/td>\n1341.8890<\/td>\nUSD<\/td>\n9<\/td>\n<\/tr>\n
GOOGL<\/td>\nAlphabet Inc<\/td>\n2019<\/td>\n1167.640000<\/td>\n1341.8890<\/td>\nUSD<\/td>\n9<\/td>\n<\/tr>\n
BKNG<\/td>\nBooking Holdings Inc<\/td>\n2019<\/td>\n1829.850000<\/td>\n2062.0000<\/td>\nUSD<\/td>\n5<\/td>\n<\/tr>\n
ISRG<\/td>\nIntuitive Surgical Inc<\/td>\n2019<\/td>\n495.310000<\/td>\n590.0000<\/td>\nUSD<\/td>\n4<\/td>\n<\/tr>\n
VRTX<\/td>\nVertex Pharmaceuticals Inc<\/td>\n2019<\/td>\n168.850000<\/td>\n216.6000<\/td>\nUSD<\/td>\n5<\/td>\n<\/tr>\n
TSLA<\/td>\nTesla Inc<\/td>\n2019<\/td>\n239.520000<\/td>\n297.3333<\/td>\nUSD<\/td>\n6<\/td>\n<\/tr>\n
REGN<\/td>\nRegeneron Pharmaceuticals Inc<\/td>\n2019<\/td>\n312.860000<\/td>\n414.3333<\/td>\nUSD<\/td>\n6<\/td>\n<\/tr>\n
MELI<\/td>\nMercadoLibre Inc<\/td>\n2019<\/td>\n557.840000<\/td>\n625.0000<\/td>\nUSD<\/td>\n2<\/td>\n<\/tr>\n
NTRSP<\/td>\nNorthern Trust Corp<\/td>\n2019<\/td>\n25.530000<\/td>\n105.5000<\/td>\nUSD<\/td>\n2<\/td>\n<\/tr>\n
IAC<\/td>\nIAC\/InterActiveCorp<\/td>\n2019<\/td>\n228.020000<\/td>\n282.6000<\/td>\nUSD<\/td>\n5<\/td>\n<\/tr>\n
ZBRA<\/td>\nZebra Technologies Corp<\/td>\n2019<\/td>\n195.890000<\/td>\n250.0000<\/td>\nUSD<\/td>\n2<\/td>\n<\/tr>\n
SRPT<\/td>\nSarepta Therapeutics Inc<\/td>\n2019<\/td>\n122.000000<\/td>\n213.6000<\/td>\nUSD<\/td>\n5<\/td>\n<\/tr>\n
IPGP<\/td>\nIPG Photonics Corp<\/td>\n2019<\/td>\n153.690000<\/td>\n201.3333<\/td>\nUSD<\/td>\n3<\/td>\n<\/tr>\n
RGLD<\/td>\nRoyal Gold Inc<\/td>\n2020<\/td>\n82.920000<\/td>\n135.5371<\/td>\nCAD<\/td>\n2<\/td>\n<\/tr>\n
TLRY<\/td>\nTilray Inc<\/td>\n2019<\/td>\n49.850000<\/td>\n200.0000<\/td>\nUSD<\/td>\n1<\/td>\n<\/tr>\n
GBT<\/td>\nGlobal Blood Therapeutics Inc<\/td>\n2019<\/td>\n58.830000<\/td>\n111.6667<\/td>\nUSD<\/td>\n3<\/td>\n<\/tr>\n
ICPT<\/td>\nIntercept Pharmaceuticals Inc<\/td>\n2019<\/td>\n86.660000<\/td>\n166.5000<\/td>\nUSD<\/td>\n6<\/td>\n<\/tr>\n
LGND<\/td>\nLigand Pharmaceuticals Inc<\/td>\n2019<\/td>\n116.260000<\/td>\n202.0000<\/td>\nUSD<\/td>\n2<\/td>\n<\/tr>\n
ANAB<\/td>\nAnaptysBio Inc<\/td>\n2019<\/td>\n74.510000<\/td>\n121.7500<\/td>\nUSD<\/td>\n4<\/td>\n<\/tr>\n
MDGL<\/td>\nMadrigal Pharmaceuticals Inc<\/td>\n2019<\/td>\n103.610000<\/td>\n240.0000<\/td>\nUSD<\/td>\n4<\/td>\n<\/tr>\n
HIIQ<\/td>\nHealth Insurance Innovations Inc<\/td>\n2019<\/td>\n20.320000<\/td>\n68.0000<\/td>\nUSD<\/td>\n3<\/td>\n<\/tr>\n
AXGT<\/td>\nAxovant Gene Therapies Ltd<\/td>\n2020<\/td>\n8.410000<\/td>\n56.0000<\/td>\nUSD<\/td>\n1<\/td>\n<\/tr>\n
CATB<\/td>\nCatabasis Pharmaceuticals Inc<\/td>\n2019<\/td>\n7.510000<\/td>\n72.0000<\/td>\nUSD<\/td>\n1<\/td>\n<\/tr>\n
WWR<\/td>\nWestwater Resources Inc<\/td>\n2019<\/td>\n4.750000<\/td>\n75.0000<\/td>\nUSD<\/td>\n1<\/td>\n<\/tr>\n<\/table>\n

Let’s look at a few companies…<\/h4>\n

Lets look at a couple of the companies on this list to get a better understanding of them.<\/p>\n

BKNG:NAS Booking Holdings<\/h6>\n

https:\/\/www.bookingholdings.com<\/a>
\nBooking Holdings has 25600 employees and is headquartered in United States.
\nBooking Holdings Inc is an online travel agency. The firm through its branded sites offer booking services for hotel rooms, airline tickets, rental restaurant reservations, cruises, and other vacation packages.<\/p>\n

VRTX:NAS Vertex Pharmaceuticals<\/h6>\n

http:\/\/www.vrtx.com<\/a>
\nVertex Pharmaceuticals has 2500 employees and is headquartered in United States.
\nVertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets. Its products include SYMDEKO, ORKAMBI, and KALYDECO.<\/p>\n

Free Valuation<\/h4>\n

Run a valuation on any of the companies listed above at www.stockcalc.com\/valureport.aspx<\/a> or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports<\/a>.<\/p>\n

The content presented here is in part from the website stockcalc.com<\/a> and is provided on an as is<\/strong> or as available<\/strong> basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.<\/em><\/p>\n

<\/div>\n
\n

Wait! We want you to try StockCalc for<\/span><\/h2>\n

30 Days for Free!<\/h1>\n

Yes, I want to find out what my stocks are worth<\/span><\/a>
\n No, I don’t want to know the value of my stocks<\/span><\/a>\n <\/div>\n